Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.

Author: AkhtarShahzad, DesaiAmit, HanDavid, KatoKota, KovandaLaura, KowalskiDonna, LademacherChristopher, TownsendRobert, YamazakiTakao

Paper Details 
Original Abstract of the Article :
This phase 1, open-label study evaluated the pharmacokinetic effects of coadministration of the antifungal agent, isavuconazole (administered as its water-soluble prodrug isavuconazonium sulfate), with the antiretroviral agent lopinavir/ritonavir in healthy adults. In part 1, 13 subjects were random...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297880/

データ提供:米国国立医学図書館(NLM)

Decoding the Pharmacokinetic Interactions Between Isavuconazole and Lopinavir/Ritonavir

In the vast desert of pharmaceutical interactions, navigating the complex relationships between different medications can be a challenging endeavor. This study, like an intrepid traveler mapping a new territory, investigates the pharmacokinetic interaction between isavuconazole, an antifungal agent, and lopinavir/ritonavir, an antiretroviral combination. The study, conducted in healthy subjects, revealed a significant interplay between these two medications. Isavuconazole's exposure increased when co-administered with lopinavir/ritonavir, while lopinavir/ritonavir exposure decreased in the presence of isavuconazole. This discovery emphasizes the importance of careful monitoring for reduced antiviral efficacy when co-administering these agents.

The Impact of Drug Interactions on Treatment Efficacy

This study highlights the crucial role of pharmacokinetic interactions in drug efficacy. It demonstrates that co-administration of isavuconazole and lopinavir/ritonavir can alter the levels of these drugs in the body, potentially impacting their effectiveness. Therefore, it is essential for healthcare providers to be aware of such interactions and adjust treatment strategies accordingly.

Navigating the Desert of Drug Interactions: A Guide for Patients

The findings of this study serve as a reminder that even seemingly unrelated medications can interact with each other. It is crucial for patients to consult with their healthcare providers about any medications they are taking, including over-the-counter drugs, herbal supplements, and even food. By proactively communicating with their healthcare team, patients can ensure that their medications are working effectively and safely.

Dr.Camel's Conclusion

This research sheds light on the complexities of drug interactions, reminding us that just like a camel caravan needs to navigate treacherous sand dunes, healthcare professionals must carefully manage the interactions between medications. Understanding these interactions is essential for ensuring that patients receive safe and effective treatment. By recognizing the potential for these interactions, we can pave the way for safer and more successful therapeutic outcomes.

Date :
  1. Date Completed 2018-05-25
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

27273248

DOI: Digital Object Identifier

PMC5297880

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.